Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: NASDAQ GM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

CRIS:US

3.8300 USD 0.0500 1.32%

As of 17:20:00 ET on 05/24/2013.

Company Profile for Curis Inc (CRIS)

Curis, Inc. develops therapeutics for the regeneration and restoration of human tissues and organs.

Contact Information

Curis Inc

4 Maguire Road
Lexington, MA 02421
United States
Phone: 1-617-503-6500

Key Executives for Curis Inc (CRIS)

Daniel R PasseriChief Executive OfficerAli R FattaeyPresident/COO
Michael P GrayChief Financial OfficerMaurizio VoiExec VP/Chief Medical Officer
Mark W NoelVP:Technology Management

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil